Your Article Summary
Use of Cardioprotective Medications in Kidney Transplant Recipients
American Journal of Transplantation, 06/12/09
Gaston RS et al. - This study demonstrates marked variability in the use of cardioprotective medications in kidney transplant recipients, a finding that may reflect, among several possible explanations, clinical uncertainty due the lack of randomized trials for these medications in this population.
Related Articles
The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09
Relevance Score: 70%
The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09
Relevance Score: 70%
ABO-Incompatible Kidney Transplantation
Transplantation, 10/29/09
Relevance Score: 70%
Ethical Issues and Living Unrelated Donor Kidney Transplantation
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 69%
The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 69%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Arteriovenous fistula in an autotransplanted kidney segment: Successful angiographic management
Scandinavian Journal of Urology and Nephrology, 12/04/09
Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival
Nephrology Dialysis Transplantation, 12/04/09
Echocardiographic findings in kidney transplant patients with autosomal dominant polycystic kidney disease
Scandinavian Journal of Urology and Nephrology, 12/04/09

See Latest Articles